Literature DB >> 16251604

Reduced adiposity in bitter melon (Momordica charantia)-fed rats is associated with increased lipid oxidative enzyme activities and uncoupling protein expression.

Laureen L Y Chan1, Qixuan Chen, Adi G G Go, Emily K Y Lam, Edmund T S Li.   

Abstract

To further explore the antiobesity effect of freeze-dried bitter melon (BM) juice, activities of mitochondrial lipid oxidative enzymes as well as the expression of uncoupling proteins and their transcription coactivator peroxisome proliferator-activated receptor-gamma coactivator-1 alpha (PGC-1alpha) were determined in diet-induced obese (DIO) rats. Rats were fed high-fat (HF) diets to induce obesity, and the effect of BM was assessed at doses of 0.75, 1.0, or 1.25% (wt:wt). In a dose-response experiment, BM-supplemented rats had lower energy efficiency (g weight gained/kJ consumed), visceral fat mass, serum glucose, and insulin resistance index, but higher plasma norepinephrine than unsupplemented rats (P < 0.05). Hepatic and skeletal muscle triglyceride concentrations were lower in supplemented HF diet-fed rats than in unsupplemented HF diet-fed rats (P < 0.05). An HF diet supplemented with BM elevated activities of hepatic and muscle mitochondrial carnitine palmitoyl transferase-I (CPT-I) and acyl-CoA dehydrogenase (AD) (P < 0.05). In another experiment, BM (1.0 g/100 g) lowered visceral fat mass but increased serum adiponectin concentration in HF diet-fed rats (P < 0.05). In the final study, rats were fed the HF diet with 0, 1.0 or 1.25% BM. Both groups of BM-supplemented rats had higher uncoupling protein 1 in brown adipose tissue (P < 0.05) and uncoupling protein 3 in red gastrocnemius muscle (P < 0.05), measured by Western blotting and RT-PCR, than the controls. The expression of the transcription coactivator PGC-1alpha in both tissues was also significantly elevated in the BM-supplemented rats (P < 0.05). The present results suggest that decreased adiposity in BM-supplemented rats may result from lower metabolic efficiency, a consequence of increased lipid oxidation and mitochondrial uncoupling.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16251604     DOI: 10.1093/jn/135.11.2517

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  10 in total

1.  Bioactives from bitter melon enhance insulin signaling and modulate acyl carnitine content in skeletal muscle in high-fat diet-fed mice.

Authors:  Zhong Q Wang; Xian H Zhang; Yongmei Yu; Alexander Poulev; David Ribnicky; Z Elizabeth Floyd; William T Cefalu
Journal:  J Nutr Biochem       Date:  2011-01-28       Impact factor: 6.048

2.  Lipid lowering effects of Momordica charantia (Bitter Melon) in HIV-1-protease inhibitor-treated human hepatoma cells, HepG2.

Authors:  Pratibha V Nerurkar; Yun Kyung Lee; Ellen H Linden; Steven Lim; Laurel Pearson; Jennifer Frank; Vivek R Nerurkar
Journal:  Br J Pharmacol       Date:  2006-07-03       Impact factor: 8.739

Review 3.  Regulation of energy metabolism pathways by estrogens and estrogenic chemicals and potential implications in obesity associated with increased exposure to endocrine disruptors.

Authors:  Jin-Qiang Chen; Terry R Brown; Jose Russo
Journal:  Biochim Biophys Acta       Date:  2009-04-05

4.  Momordica charantia (bitter melon) inhibits primary human adipocyte differentiation by modulating adipogenic genes.

Authors:  Pratibha V Nerurkar; Yun-Kung Lee; Vivek R Nerurkar
Journal:  BMC Complement Altern Med       Date:  2010-06-29       Impact factor: 3.659

5.  Momordica charantia (Bitter Melon) reduces obesity-associated macrophage and mast cell infiltration as well as inflammatory cytokine expression in adipose tissues.

Authors:  Bin Bao; Yan-Guang Chen; Lei Zhang; Yan Lin Na Xu; Xin Wang; Jian Liu; Wei Qu
Journal:  PLoS One       Date:  2013-12-17       Impact factor: 3.240

Review 6.  Beneficial role of bitter melon supplementation in obesity and related complications in metabolic syndrome.

Authors:  Md Ashraful Alam; Riaz Uddin; Nusrat Subhan; Md Mahbubur Rahman; Preeti Jain; Hasan Mahmud Reza
Journal:  J Lipids       Date:  2015-01-12

Review 7.  Recent Advances in Momordica charantia: Functional Components and Biological Activities.

Authors:  Shuo Jia; Mingyue Shen; Fan Zhang; Jianhua Xie
Journal:  Int J Mol Sci       Date:  2017-11-28       Impact factor: 5.923

8.  Protective effect of Momordica charantia water extract against liver injury in restraint-stressed mice and the underlying mechanism.

Authors:  Yuanyuan Deng; Qin Tang; Yan Zhang; Ruifen Zhang; Zhencheng Wei; Xiaojun Tang; Mingwei Zhang
Journal:  Food Nutr Res       Date:  2017-07-13       Impact factor: 3.894

Review 9.  The Effect of Momordica charantia in the Treatment of Diabetes Mellitus: A Review.

Authors:  Zhuo Liu; Jing Gong; Wenya Huang; Fuer Lu; Hui Dong
Journal:  Evid Based Complement Alternat Med       Date:  2021-01-16       Impact factor: 2.629

10.  Altered white adipose tissue protein profile in C57BL/6J mice displaying delipidative, inflammatory, and browning characteristics after bitter melon seed oil treatment.

Authors:  Cheng-Hsien Hsieh; Gou-Chun Chen; Pei-Hsuan Chen; Ting-Feng Wu; Pei-Min Chao
Journal:  PLoS One       Date:  2013-09-06       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.